Clinical Trials Browser

Phase 4 × Dexamethasone × Plasma cell × Clear all

NCT07101445 2026-02-10

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Phase 4 Recruiting

Multiple Myeloma

NCT07334535 2026-01-13

Isa-VRD in TIE HRMM

Phase 4 Not yet recruiting

Multiple Myeloma

NCT03829371 2025-12-03

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

Phase 4 Active not recruiting

Multiple Myeloma

NCT07025005 2025-11-04

VRd MM Fibrate

Phase 4 Recruiting

Multiple Myeloma, Neoplasms, Peripheral Nervous System Diseases

NCT03934684 2025-08-06

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Phase 4 Completed

101 enrolled 11 charts

Multiple Myeloma

NCT06409702 2025-06-12

Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection

Phase 4 Recruiting

Multiple Myeloma

NCT05183139 2022-05-03

US MM-7

Phase 4 Withdrawn

Multiple Myeloma

NCT01731886 2020-02-05

Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma

Phase 4 Completed

60 enrolled 14 charts

Multiple Myeloma

NCT02577783 2020-02-05

PDD vs PAD to Treat Initially Diagnosed MM

Phase 4 Unknown

Multiple Myeloma